A retrospective observational study to evaluate patient-reported outcomes (PROs) in patients with metastatic ALK plus non-small cell lung cancer (NSCLC) treated with ALK inhibitors Meeting Abstract

Industry Collaboration

cited authors

  • Biber, Josh; Wan, Yin; Churchill, Eric N.; Danes, Christopher G.; Socinski, Mark A.; Spira, Alexander I.

authors

Publication Date

  • July 1, 2024

webpage

published in

category

start page

  • E36

end page

  • E36

volume

  • 19

issue

  • 7